EP 195: From junk to therapy: The untapped power of regulatory RNAs with David Bumcrot of CAMP4 Therapeutics

<p><strong>Summary: </strong></p><p>This week on The Genetics Podcast, Patrick is joined by David Bumcrot, Chief Scientific Officer of CAMP4 Therapeutics. They discuss David’s involvement in the development of the breakthrough technologies in RNA interference and CRISPR, how CAMP4 is pioneering the use of regulatory RNAs to treat haploinsufficient diseases, and the complexities of gene regulation.</p><p> </p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>00:59</strong> Welcome to David </p><p><strong>01:57 </strong>David’s experiences at companies that developed RNA interference (RNAi) and CRISPR technologies</p><p><strong>04:05 </strong>Lessons from translating RNAi to the bedside </p><p><strong>05:58</strong> The scalable chemistry of RNA versus the complexity of gene editing</p><p><strong>07:48 </strong>Insight into the lack of rapid scalability and growth in gene therapy companies</p><p><strong>09:19 </strong>How CAMP4 is us...